Literature DB >> 32896936

TANK-binding kinase 1 mediates osteoclast differentiation by regulating NF-κB, MAPK and Akt signaling pathways.

Shuai Lin1, Xiao-Li Zhao1, Zhen Wang1.   

Abstract

TANK-binding kinase 1 (TBK1) belongs to the noncanonical IκB kinase (IKK) family. The ubiquitously expressed protein is well known to play a pivotal role in innate immune response and inflammation. Although excessive inflammatory activities have been shown to affect osteoclast (OC) differentiation and function, direct relevance of TBK1 in bone turnover is not known. In this work, we specifically altered the TBK1 protein level by knocking down or overexpressing it without affecting its homologous protein IKKε expression, and demonstrated the effect of TBK1 on OC differentiation in bone marrow macrophages (BMMs) and RAW264.7 cells upon induction by receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL). TBK1 knockdown was found to markedly inhibit the OC differentiation and function, while TBK1 overexpression enhanced OC formation. Downregulation of TBK1 greatly suppressed RANKL-induced gene expression of Mmp9, Atp6v0d2, Acp5, Ctsk andNfatc1 involved in the regulation of OC formation and function in both BMM and RAW264.7 cells. Mechanistic studies indicated that TBK1 affected the NF-κB signaling pathway as well as mitogen-activated protein kinases (MAPKs) and protein kinase B (Akt) activation during OC differentiation. Moreover, the protein level of TNF receptor-associated factor 6 (TRAF6) was increased, and the interaction of TRAF6 with TBK1 was potentiated, by RANKL. Collectively, we provide direct evidence showing that TBK1 effectively mediates OC differentiation and function by regulating NF-κB, MAPKs and Akt signals. A TBK1-targeted therapeutic strategy may be useful for the treatment of bone-related disorders.
© 2020 Australian and New Zealand Society for Immunology, Inc.

Entities:  

Keywords:  Bone turnover; TANK-binding kinase 1; nuclear factor-κB; osteoclast differentiation

Year:  2020        PMID: 32896936     DOI: 10.1111/imcb.12401

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  5 in total

1.  TANK-binding kinase 1 inhibitor GSK8612 enhances daunorubicin sensitivity in acute myeloid leukemia cells via the AKT-CDK2 pathway.

Authors:  Siyu Chen; Ming Ni; Tianzhen Hu; Yangguang Gu; Cheng Feng; Chengyun Pan; Siyu Zhang; Shuangshuang Wen; Naiqin Zhao; Weili Wang; Lihong Dai; Jishi Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Silence of TANK-binding kinase 1 (TBK1) regulates extracellular matrix degradation of chondrocyte in osteoarthritis by janus kinase (JAK)-signal transducer of activators of transcription (STAT) signaling.

Authors:  Peng Sun; Yuan Xue
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

3.  Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking.

Authors:  Fuyu Tang; Peng Zhang; Wenhua Zhao; Guangye Zhu; Gengyang Shen; Honglin Chen; Xiang Yu; Zhida Zhang; Qi Shang; Xiaobing Jiang; Hui Ren
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-03       Impact factor: 2.629

4.  LncRNA-mRNA Expression Profiles of Osteoclast After Conditional Knockout HIF-1α.

Authors:  Yuanye Tian; Qi Shao; Jiahong Gu; Yi Tang; Miaomiao Bie; Yangyifan Zhou; Chunan Cheng; Yi Liang; Qian Zhang; Feiwu Kang
Journal:  Front Genet       Date:  2022-06-21       Impact factor: 4.772

5.  miR-135a-5p Suppresses TBK1 and Activates NRF2/TXNIP Antioxidant Pathway in LPS-Driven ALI in Mice.

Authors:  Guotao Zou; Yiwen Zeng; Yingjuan Wang; Yong Luo
Journal:  Comput Math Methods Med       Date:  2022-07-20       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.